Search Within

Jacob Ezra Tallman

Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
  3. Correspondence (2)
Groups
  1. GME, Surgery (17)
  2. Graduate Medical Education (17)
  3. Surgery (14)
  4. Urology (14)
  5. Department of Medicine (11)
  6. GSK Faculty (11)

More Groups

People
  1. Eugene Pietzak (11)
  2. Bernard Bochner (9)
  3. David Solit (9)
  4. Hikmat Al-Ahmadie (9)
  5. Gopakumar Iyer (8)
  6. Syed Alam (8)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2014 (2)
Publications
  1. Urologic Oncology: Seminars and Original Investigations (4)
  2. Journal of Urology (3)
  3. European Urology (2)
  4. Laboratory Investigation (2)
  5. Blood (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (5)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (2)
  4. American Medical Association (1)
  5. American Society of Clinical Oncology (1)
  6. American Society of Hematology (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Response to 2 induction courses of bacillus Calmette-Guè€rin therapy among patients with high-risk non-muscle-invasive bladder cancer: 5-year follow-up of a phase 2 clinical trial
    Journal Article

    Katims, A. B.; Tallman, J.; Vertosick, E.; Porwal, S.; Dalbagni, G.; Cha, E. K.; Smith, R.; Benfante, N.; Herr, H. W.
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Clinical, molecular and immunohistochemical profiles of clear cell adenocarcinoma of the urinary tract
    Meeting Abstract

    Koll, F.; Rammal, R.; Chen, Z.; Basar, M.; Alam, S. M.; Tallman, J. E.; Pietzak, E.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid lukemia
    Meeting Abstract

    Rampal, R. K.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J. P.; Li, Y. S.; Ahn, J.; Abdel-Wahab, O.; Shih, A. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia
    Journal Article

    Rampal, R.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J.; Li, Y.; Ahn, J.; Abdel-Wahab, O.; Shih, A.; more...
    Cell Reports (2014)

    Fulltext@MSK | Save